Table 4.

Multivariable associations between preference for current ART over long-acting antiretroviral therapy and selected participant characteristics.

	Adjusted odds ratio	95% CI	P-value
Washington State	0.43	(0.22–0.83)	0.01
Age <30	0.27	(0.06–1.27)	0.10
Age 30–49	0.56	(0.30–1.06)	0.07
Education – high school or less	2.73	(1.41–5.27)	<0.01
Good adherencea	2.51	(1.42–4.46)	<0.01
Substance useb
Tobacco	1.92	(0.99–3.71)	0.05
Alcohol	2.03	(0.96–4.27)	0.06
Aversion to injectionsc	2.63	(1.50–4.59)	<0.01
No consent to link chart data	1.93	(0.71–5.22)	0.20
PNTS – education	4.37	(1.29–14.78)	0.02
PNTS – HIV-relatedd	0.76	(0.12–4.88)	0.77
PNTS – other health-relatede	2.83	(0.71–11.30)	0.14

Results of a multivariable logistic regression with robust standard errors, and a binary dependent variable equal to 1 if the participant chose to remain on their current daily oral therapy in 100% of choice scenarios in a discrete choice experiment examining preferences for long-acting antiretroviral therapies among 700 people living with HIV aged 18+ in Washington State and Atlanta, Georgia.

ART, antiretroviral therapy; PNTS prefer not to say.

^aGood adherence was defined as reporting to always or almost always take ART as instructed.

^bSubstance use was extracted from medical chart review.

^cAversion to injections was defined as reporting to strongly agree or somewhat agree with the statement ‘I HATE getting injections and try to avoid getting them whenever possible.’

^dHIV-related characteristics (preferred not to disclose) included ART initiation year, HIV diagnosis year, number of past regimens, ART adherence, and getting to clinic easily.

^eOther health-related characteristics (preferred not to disclose) included number of non-HIV pills, and aversion to injections.